On Tuesday, investment group Eurazeo announced that it had acquired a stake in Oncodesign Services, a company specializing in drug discovery and pre-clinical services in oncology and.
The Nov Santé Actions Non Cotées fund, managed by Eurazeo and dedicated to the development of healthcare sectors in Europe, has announced the completion of its first growth equity investment in.
The Paris Bourse ended the session up 1.13% at 7,401 points, helped by a rebound in the luxury goods sector with +2.5% for LVMH, +2.2% for Kering and +1.8% for Hermès. On the statistics front, the.
SEQENS, an integrated leader in the manufacturing of active ingredients and pharmaceutical intermediates, announced a multi-million-dollar investment in its research and development laboratory located in Devens, Mass.